A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT07365995 · RECRUITING
Trial details
- NCT number
- NCT07365995
- Sponsor
- BioNTech SE
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2031-02-01
- Enrollment
- 736
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.